Author

Ntalianis A

MD, PhD, Alexandra General Hospital, National and Kapodistrian University of Athens, School of Medicine Department of Clinical Therapeutics - Cited by 3,613 - Cardiology

Biography

He is affiliated to University of Athens, School of Medicine, 3rd Cardiology Department, Athens, Greece. He is a recipient of many awards and grants for his valuable contributions and discoveries in major area of subject research. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals.
Title
Cited by
Year
Cardio-oncology: a focus on cardiotoxicity
A Koutsoukis, A Ntalianis, E Repasos, E Kastritis, MA Dimopoulos, ...European Cardiology Review 13 (1), 64, 2018201
79
2018
Addition of cyclophosphamide and higher doses of dexamethasone do not improve outcomes of patients with AL amyloidosis treated with bortezomib
E Kastritis, M Gavriatopoulou, M Roussou, D Fotiou, DC Ziogas, M Migkou, ...Blood Cancer Journal 7 (6), e570-e570, 2017201
41
2017
Primary treatment of light-chain amyloidosis with bortezomib, lenalidomide, and dexamethasone
E Kastritis, I Dialoupi, M Gavriatopoulou, M Roussou, N Kanellias, ...Blood advances 3 (20), 3002-3009, 2019201
39
2019
Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology
U Zeymer, P Ludman, N Danchin, P Kala, C Laroche, M Sadeghi, ...European heart journal 42 (44), 4536-4549, 2021202
31
2021
Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis
E Kastritis, M Gavriatopoulou, M Roussou, T Bagratuni, M Migkou, ...Amyloid 25 (4), 234-241, 2018201
30
2018
Next generation flow cytometry for MRD detection in patients with AL amyloidosis
E Kastritis, IV Kostopoulos, F Theodorakakou, D Fotiou, M Gavriatopoulou, ...Amyloid 28 (1), 19-23, 2021202
24
2021
Timing and impact of a deep response in the outcome of patients with systemic light chain (AL) amyloidosis
E Kastritis, D Fotiou, F Theodorakakou, I Dialoupi, M Migkou, M Roussou, ...Amyloid 28 (1), 3-11, 2021202
22
2021
The acute and long-term effects of a cardiac rehabilitation program on endothelial progenitor cells in chronic heart failure patients: Comparing two different exercise training …
C Kourek, M Alshamari, G Mitsiou, K Psarra, D Delis, V Linardatou, ...IJC Heart & Vasculature 32, 100702, 212
20
2021
Endothelial progenitor cells mobilization after maximal exercise in patients with chronic heart failure
C Kourek, E Karatzanos, K Psarra, A Ntalianis, G Mitsiou, D Delis, ...Hellenic J Cardiol 62, 70-72, 2021202
11
2021
Cardiotoxicity of non-anthracycline cancer chemotherapy agents
A Briasoulis, A Chasouraki, A Sianis, N Panagiotou, C Kourek, A Ntalianis, ...Journal of Cardiovascular Development and Disease (3), 66, 2022202
9
2022
How to develop a national heart failure clinics network: a consensus document of the Hellenic Heart Failure Association
Task force of the Hellenic Heart Failure Clinics Network, G Filippatos, ...ESC Heart Failure 7 (1), 15-25, 2020202
8
2020
Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography
P Xaplanteris, A Ntalianis, B De Bruyne, T Strisciuglio, M Pellicano, ...EuroIntervention 14 (), 907-14, 20120
8
2018
Cardiac amyloidosis: in search of the ideal diagnostic tool
SI Mavrogeni, V Vasiliki, N Argyrios, V Rosa, I Ignatios, T Marini, P Ioannis, ...Herz 46, 9-14, 2021202
8
2021
Intravenous lipid emulsion as an antidote in clinical toxicology: a systematic review.
K Tampakis, N Vogiatzakis, C Kontogiannis, M Spartalis, A Ntalianis, ...European Review for Medical & Pharmacological Sciences 24 (12), 2020202
8
2020
Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper
A Ntalianis, C Chrysohoou, G Giannakoulas, G Giamouzis, A Karavidas, ...Heart Failure Reviews 2 (1), 1-13, 2022202
7
2022
Exercise promotes endothelial progenitor cell mobilization in patients with chronic heart failure
G Mitsiou, E Karatzanos, I Smilios, K Psarra, I Patsaki, HT Douda, ...European Journal of Preventive Cardiology 28 (18), e24-e27, 2021202
5
2021
Intracoronary administration of allogeneic cardiosphere-derived cells immediately prior to reperfusion in pigs with acute myocardial infarction reduces infarct size and …
V Sousonis, T Sfakianaki, A Ntalianis, I Nanas, C Kontogiannis, ...Journal of Cardiovascular Pharmacology and Therapeutics 26 (1), 88-99, 2021202
5
2021
Effects of exercise training on diastolic and systolic dysfunction in patients with chronic heart failure
I Chaveles, O Papazachou, M Al Shamari, D Delis, A Ntalianis, ...World Journal of Cardiology 1 (9), 514, 2021202
3
2021
Distribution, infrastructure, and expertise of heart failure and cardio‐oncology clinics in a developing network: temporal evolution and challenges during the coronavirus …
Taskforce of the Hellenic Heart Failure Clinics Network, K Keramida, ...ESC Heart Failure 7 (6), 408-41, 2020202
3
2020
Practical Approaches to Build and Sustain a Cardio-Oncology Clinic
A Chasouraki, C Kourek, A Sianis, K Loritis, P Kostakou, E Tsougos, ...Journal of Cardiovascular Development and Disease 9 (5), 158, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=Zdfht60AAAAJ&hl=en

Cited by
Citations 3613
h-index 32
i10-index 55
Recommended Journals
Open Access Journals